Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase-Reference-Cited by-同舟云学术

Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase

Published:2011-03 Issue: Volume: Page:n/a-n/a
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Terevnikov Viacheslav¹,Stenberg Jan-Henry²,Tiihonen Jari,Joffe Marina²,Burkin Mark³,Tchoukhine Evgueni²,Joffe Grigori²

Affiliation:

1. Kellokoski Hospital; Kellokoski; Finland

2. Helsinki University Central Hospital; Helsinki; Finland

3. University of Petrozavodsk; Petrozavodsk; Russia

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.1189/fullpdf

Reference34 articles.

1. The effect of mirtazapine add-on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial;Abbasi;Schizophr Res,2010

2. Assessing depression in schizophrenia: the Calgary Depression Scale;Addington;Br J Psychiatry,1993

3. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale;Addington;Schizophr Res,1996

4. Depression in the long-term course of schizophrenia;An der Heiden;Eur Arch Psychiatry Clin Neurosci,2005

5. A review of the pharmacological and clinical profile of mirtazapine;Anttila;CNS Drug Rev,2001

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Efficacy in the Treatment of Antipsychotic-Induced Akathisia;JAMA Network Open;2024-03-07

2. Mirtazapine in schizophrenia – an undeservedly overlooked option?;International Clinical Psychopharmacology;2022-03-31

3. Association between depression in chronic phase and future clinical outcome of patients with schizophrenia;Psychopharmacology;2022-02-21

4. Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”;Neuropsychopharmacology Reports;2021-08-12

5. Diagnosis and Treatment of Depression in Patients with Schizophrenia;Consortium Psychiatricum;2020-12-03